This study tests an experimental oral drug called PMD-026 in people with metastatic breast cancer that has spread and is no longer curable. The drug targets a protein called RSK2 found in some tumors. The trial will check safety and how well the drug works alone or with another h…
Phase: PHASE1, PHASE2 • Sponsor: Phoenix Molecular Designs • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC